GHIT Request for Proposals: Product Development Platform

The Global Health Innovative Technology Fund (GHIT) Fund announces an investment opportunity for the development of new medicines, vaccines, diagnostics for infectious diseases that are prevalent in the developing world.

The GHIT Fund aims to advance Japan’s wealth of health technology innovation for the discovery and development of new technologies for developing world patients and populations affected by infectious disease. To this end, the GHIT Fund will catalyze R&D partnerships between Japanese and non-Japanese organizations and support these partnerships through GHIT Fund investments.

Proposal details:

• Proposed projects should address health needs in the developing world or fill a gap in global health technologies for infectious diseases.
• The proposed collaboration projects should be no more than two years in duration and may focus on a broad array of R&D activities, including:- Lead optimization,- Preclinical Development (in-vivo studies, formulation development, chemistry and process validation), – Clinical Development (Phase 1, 2, or 3 studies, manufacturing scale-up), – Activities to support licensure and WHO prequalification
• The investment scope for the RFP-PD-2023-002 is primarily focused on continuation projects, diagnostics projects, and projects beyond lead optimization (e.g. FIH and POC).

Eligibility:

• There should be at least one eligible Japanese and one eligible non-Japanese organization as partners
• Partnerships can be existing or new between Japanese and non-Japanese organizations
• Each partner should have a history of health intervention R&D and have the expertise to know which projects represent potentially substantial additions to the field
• Projects must address a priority need for the prevention or treatment of infectious diseases in developing countries.

Funding details:

• Proposal budgets should reflect the amount needed to carry out project activities.
• Two years maximum

Important dates

1. Intent to apply deadline – July 11, 2023
2. Submit Q&A deadline – August 2, 2023
3. Proposal Submission (eligible applicants will be invited to submit) –  August 9, 2023

Read more here.